Your session is about to expire
← Back to Search
Ketorolac for Acute Pancreatitis
Phase 4
Waitlist Available
Led By Anthony J Gentene, PharmD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during hospital admission
Awards & highlights
Study Summary
This trial will compare different ways of managing pain for people hospitalized with acute pancreatitis.
Eligible Conditions
- Acute Pancreatitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 to day 5 of study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 to day 5 of study
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Opioids
Secondary outcome measures
Morphine
Duration of intravenous opioid use
Trial Design
2Treatment groups
Active Control
Group I: Standard of CareActive Control1 Intervention
Patients receiving standard of care pain management including opioids.
Group II: KetorolacActive Control1 Intervention
Patients will receive standard of care pain management plus intravenous ketorolac.
Find a Location
Who is running the clinical trial?
University of CincinnatiLead Sponsor
427 Previous Clinical Trials
634,302 Total Patients Enrolled
Anthony J Gentene, PharmDPrincipal InvestigatorUniversity of Cincinnati
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger